Diagnostic Testing of Sexually Transmitted Diseases Market Growth Accelerated by increased Prevalence of STDs
Diagnostic testing of STDs plays a vital role in reducing the spread of sexually transmitted diseases by enabling early and accurate detection of the pathogens causing these infections. STD diagnostic tests help identify the causative agent in symptomatic as well as asymptomatic cases, facilitating prompt treatment. Growing awareness regarding the importance of regular screening, even in the absence of symptoms, and rising prevalence of STDs such as HIV, chlamydia, gonorrhea, and syphilis globally are fueling demand for advanced diagnostic solutions. The global Diagnostic Testing of STDs Market is estimated to be valued at US$ 10.04 Bn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increased prevalence of STDs is one of the major drivers of the diagnostic
testing of STDs market. As per the WHO, every day more than 1 million cases
of STDs are reported globally. Untreated STDs can increase the risk of
acquiring and transmitting HIV. Lack of symptoms in some cases and inadequate
treatment are contributing to the growing prevalence of chlamydia, gonorrhea,
syphilis and other STDs. Technological advancements are expanding diagnostic
capabilities, with rapid point-of-care tests that provide results in minutes
rather than the hours or days required by conventional tests. Development of
multi-analyte panels allows testing of multiple pathogens from a single
specimen, improving testing efficiency. This trend towards automated, rapid,
and multi-analyte testing solutions is expected to further propel market growth
over the forecast period.
The global diagnostic testing of STDs market is dominated by diagnostic laboratories segment. Diagnostic laboratories are the primary destination for STD testing as they have advanced infrastructure, skilled healthcare professionals and offer a range of testing options. With rising awareness about STDs, preference for licensed diagnostic laboratories is increasing owing to reliability of their test results.
Key Takeaways
The global diagnostic testing of STDs market is expected to witness high growth over the forecast period. Rapid test kits segment is dominating the market due to the convenience offered by quick detection of sexually transmitted diseases. The segment is expected to grow at a CAGR of 10.2% during 2023-2030.
Regional analysis: North America dominates the global market and is expected to maintain its position over the forecast period. High prevalence of STDs and favorable reimbursement policies are major factors driving the market in the region. Asia Pacific is expected to witness fastest growth owing to growing awareness, increasing healthcare expenditure and presence of emerging economies.
Key players: Key players operating in the diagnostic testing of STDs market are Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories. Vela Diagnostics and Roche Holdings have strong product portfolio and are investing in new product launches to strengthen their market position.

Comments
Post a Comment